KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Return on Assets (2016 - 2025)

Historic Return on Assets for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to 0.04%.

  • Teva Pharmaceutical Industries' Return on Assets rose 700.0% to 0.04% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.04%, marking a year-over-year increase of 700.0%. This contributed to the annual value of 0.04% for FY2025, which is 800.0% up from last year.
  • Teva Pharmaceutical Industries' Return on Assets amounted to 0.04% in Q4 2025, which was up 700.0% from 0.02% recorded in Q3 2025.
  • Teva Pharmaceutical Industries' Return on Assets' 5-year high stood at 0.04% during Q4 2025, with a 5-year trough of 0.08% in Q1 2021.
  • Its 5-year average for Return on Assets is 0.03%, with a median of 0.04% in 2025.
  • Data for Teva Pharmaceutical Industries' Return on Assets shows a peak YoY increase of 1000bps (in 2021) and a maximum YoY decrease of -800bps (in 2021) over the last 5 years.
  • Teva Pharmaceutical Industries' Return on Assets (Quarter) stood at 0.01% in 2021, then crashed by -710bps to 0.06% in 2022, then dropped by -18bps to 0.07% in 2023, then soared by 62bps to 0.03% in 2024, then soared by 259bps to 0.04% in 2025.
  • Its Return on Assets stands at 0.04% for Q4 2025, versus 0.02% for Q3 2025 and 0.0% for Q2 2025.